Vietnam In-Vitro Diagnostics (IVD) Market Outlook to 2030

Vietnam In-Vitro Diagnostics Market Overview

• The Vietnam In-Vitro Diagnostics (IVD) market is valued at USD 226 million, based on a five-year historical analysis. This market is primarily driven by an increasing burden of chronic diseases, including diabetes, cardiovascular diseases, and cancer, necessitating more frequent and advanced diagnostic solutions. Key drivers also include government initiatives to enhance healthcare infrastructure, and the growing adoption of point-of-care testing and molecular diagnostics techniques for early disease detection and management. These factors are fueling demand across hospitals, diagnostics laboratories, and research institutes, creating a robust outlook for the markets growth trajectory.
• Vietnams IVD market is primarily dominated by the southern region, particularly in cities such as Ho Chi Minh City. This dominance is due to the region's well-developed healthcare infrastructure, higher concentration of diagnostic laboratories, and the presence of a larger patient base. Furthermore, the southern region has more advanced healthcare facilities and a stronger presence of multinational companies offering IVD solutions, making it a significant contributor to the overall market growth.
• This decree outlines stringent regulations for the classification, registration, and post-market surveillance of medical devices in Vietnam. The decrees provisions require all medical devices to be registered with the Ministry of Health, and they stipulate mandatory safety and performance requirements that manufacturers must meet to ensure product quality and patient safety.

Vietnam In-Vitro Diagnostics Market Segmentation

By Product Type: The Vietnam IVD market is segmented by product type into Reagents & Kits, Instruments, and Software & Services. Reagents and kits currently hold a dominant market share due to their recurring demand in diagnostic testing procedures, especially for clinical chemistry, hematology, and molecular diagnostics. The usage of reagents is essential for conducting various diagnostic tests, making them a critical consumable in clinical settings.

By Technology: The Vietnam IVD market is segmented by technology into Immunoassay/Immunochemistry, Molecular Diagnostics, Clinical Chemistry, Hematology, Microbiology, and Others. The molecular diagnostics segment has emerged as the fastest-growing technology due to its capability for early and precise detection of infectious and chronic diseases. Molecular diagnostics techniques such as PCR and next-generation sequencing are extensively used in cancer diagnostics, genetic testing, and infectious disease testing.

Vietnam In-Vitro Diagnostics (IVD) Market Competitive Landscape

The Vietnam IVD market is dominated by several key players, both global and local. The market is highly consolidated, with the top companies accounting for a significant share of the overall market revenue. Major players are focusing on product innovation, strategic alliances, and geographical expansion to strengthen their market positions. The Vietnam IVD market is currently led by multinational companies such as Abbott, Danaher, and Roche Diagnostics, which have established robust distribution networks and strong customer relationships.

Vietnam In-Vitro Diagnostics (IVD) Industry Analysis

Growth Drivers

• Rising Prevalence of Chronic Diseases (e.g., Diabetes, Cardiovascular Diseases, Cancer): Chronic diseases, particularly cardiovascular diseases (CVDs), are a significant health burden in Vietnam. CVDs account for approximately 31% of all deaths in the country, with over 170,000 fatalities annually. The prevalence of hypertension among adults aged 18-69 years is 18.9%, indicating a high-risk factor for heart diseases and stroke.
• Growing Geriatric Population: Vietnams population is aging rapidly. According to WHO data, the average life expectancy has increased to 73.8 years, reflecting the demographic shift toward an older population. This trend significantly impacts the prevalence of age-related diseases such as diabetes, cardiovascular conditions, and cancer, leading to increased demand for diagnostics and healthcare services tailored for the elderly.
• Technological Advancements in IVD Solutions: Technological innovations in In-Vitro Diagnostics (IVD) have enabled the adoption of advanced diagnostic solutions such as molecular diagnostics, immunoassays, and digital pathology. The integration of artificial intelligence and machine learning into diagnostic tools is enhancing the accuracy of disease detection and prognosis, which is critical for managing the high burden of non-communicable diseases (NCDs) in the country.

Market Challenges

• High Initial Investment in Advanced Diagnostics: The adoption of advanced diagnostic technologies involves significant initial investment costs, especially in terms of acquiring equipment and maintaining quality standards. In low- and middle-income settings like Vietnam, these costs pose a substantial barrier to the widespread deployment of cutting-edge IVD technologies, limiting access mainly to urban centers and high-end hospitals.
• Regulatory Compliance and Certification Processes: Vietnam has strict regulatory requirements for medical devices, particularly under Decree No. 98/2021, which oversees the classification, certification, and registration of all medical devices. Meeting these compliance standards involves a detailed and time-consuming approval process, especially for Class C and D devices that require Marketing Authorization Codes (MAC). This can delay market entry and increase compliance costs for companies looking to introduce new diagnostic technologies.

Vietnam In-Vitro Diagnostics (IVD) Market Future Outlook

Over the next five years, the Vietnam In-Vitro Diagnostics (IVD) market is expected to witness steady growth, driven by rising demand for advanced diagnostic technologies, expansion of healthcare infrastructure, and an increasing geriatric population that necessitates more frequent health check-ups. Government initiatives aimed at expanding diagnostic capabilities and reducing the burden of chronic diseases will further support the market's growth trajectory. Technological advancements in areas such as point-of-care testing and molecular diagnostics will play a pivotal role in enhancing the market's value.

Market Opportunities

• Adoption of Point-of-Care Testing (POCT) Solutions: Point-of-Care Testing (POCT) solutions are gaining traction in Vietnam due to their ability to provide rapid results and improve diagnostic efficiency, particularly in decentralized healthcare settings. The adoption of POCT for diabetes and other chronic diseases in primary care facilities can help reduce the diagnostic gap and provide timely treatment interventions. The WHO's ongoing initiatives to expand diagnostic capabilities at commune-level health stations highlight the potential for increased POCT adoption in Vietnam.
• Expansion of Healthcare Infrastructure in Central and Southern Vietnam: The Vietnamese government is investing in the expansion of healthcare infrastructure, particularly in the central and southern regions. This includes establishing new hospitals, upgrading existing facilities, and increasing the number of healthcare professionals. These developments provide an opportunity for IVD companies to collaborate with healthcare institutions and support capacity building through the supply of diagnostic technologies and training.